4//SEC Filing
Reikes Peter N 4
Accession 0000874015-19-000106
CIK 0000874015other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 6:52 PM ET
Size
8.7 KB
Accession
0000874015-19-000106
Insider Transaction Report
Form 4
Reikes Peter N
Director
Transactions
- Award
Restricted Stock Units
2019-07-01+7,110→ 7,110 total→ Common Stock (7,110 underlying) - Award
Director Stock Option (right to buy)
2019-07-01+16,000→ 16,000 totalExercise: $64.80From: 2020-07-01Exp: 2029-06-30→ Common Stock (16,000 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- [F2]Grant of July 1, 2019 to reporting person of Restricted Stock Unit Award under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on July 1, 2020. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 1, 2023. The RSU is vested as to 0 shares on July 1, 2019.
- [F3]Grant of July 1, 2019 to reporting person of stock options under the Amended and Restated Ionis Pharmaceuticals, Inc. 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on July 1, 2020. The option shall be fully vested and exercisable on July 1, 2023. The option is exercisable to 0 shares on July 1, 2019.
Documents
Issuer
IONIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeother
Related Parties
1- filerCIK 0001753652
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 6:52 PM ET
- Size
- 8.7 KB